In vitro and pharmacokinetic properties of the carbapenems
- 1 September 1986
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 30 (3) , 343-349
- https://doi.org/10.1128/aac.30.3.343
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- β-Lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophilaJournal of Antimicrobial Chemotherapy, 1986
- Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1985
- Antibacterial Activity of Imipenem: The First Thienamycin AntibioticClinical Infectious Diseases, 1985
- Efficacy and Safety of Imipenem/Cilastatin: A Review of Worldwide Clinical ExperienceClinical Infectious Diseases, 1985
- Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactamsAntimicrobial Agents and Chemotherapy, 1985
- Disposition of radiolabeled imipenem and cilastatin in normal human volunteersAntimicrobial Agents and Chemotherapy, 1984
- The carbapenem familyJournal of Antimicrobial Chemotherapy, 1982
- N-Formimidoyl-thienamycin a novel β-actam: an in-vitro comparison with other β-lactam antibioticsJournal of Antimicrobial Chemotherapy, 1981
- N-Acetimidoyl- and N-formimidoylthienamycin derivatives: antipseudomonal .beta.-lactam antibioticsJournal of Medicinal Chemistry, 1979
- In Vitro Activity of ThienamycinAntimicrobial Agents and Chemotherapy, 1978